Cargando…
Bacteriophage-Derived Vectors for Targeted Cancer Gene Therapy
Cancer gene therapy expanded and reached its pinnacle in research in the last decade. Both viral and non-viral vectors have entered clinical trials, and significant successes have been achieved. However, a systemic administration of a vector, illustrating safe, efficient, and targeted gene delivery...
Autores principales: | Pranjol, Md Zahidul Islam, Hajitou, Amin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306838/ https://www.ncbi.nlm.nih.gov/pubmed/25606974 http://dx.doi.org/10.3390/v7010268 |
Ejemplares similares
-
Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma
por: Przystal, Justyna Magdalena, et al.
Publicado: (2019) -
Selective Inhibition of Histone Deacetylation in Melanoma Increases Targeted Gene Delivery by a Bacteriophage Viral Vector
por: Campbell, Samuel, et al.
Publicado: (2018) -
Modulation of extracellular matrix in cancer is associated with enhanced tumor cell targeting by bacteriophage vectors
por: Yata, Teerapong, et al.
Publicado: (2015) -
Thermoresponsive Bacteriophage Nanocarrier as a Gene Delivery Vector Targeted to the Gastrointestinal Tract
por: Namdee, Katawut, et al.
Publicado: (2018) -
The Potential Role of the Proteases Cathepsin D and Cathepsin L in the Progression and Metastasis of Epithelial Ovarian Cancer
por: Pranjol, Md Zahidul Islam, et al.
Publicado: (2015)